Olutasidenib

Rezlidhia

Near Add Your Location

Sorting 3 by

Accepting patients

Olutasidenib

A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.
Learn more
  • IDH1 Inhibitor
  • Phase 2

Accepting patients

Olutasidenib Combination Therapy

A Phase 2 Study Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative Neoplasm
Learn more
  • IDH1 Inhibitor
  • Phase 2

Accepting patients

Olutasidenib Maintenance

Pilot Trial of Olutasidenib Maintenance Post Allogeneic Hematopoietic Cell Transplantation in Patients Carrying IDH1 Mutation With AML, MDS, or CMML Disease
Learn more
  • IDH1 Inhibitor
  • Phase 1